reports
Immuneering Reports Third Quarter 2025 Financial Results and Provides ...
Immuneering Reports Third Quarter 2025 Financial Results and Provides Business and Clinical Updates - Announced extraordinary 86% overall survival at 9 months in first-line pancreatic cancer patients treated with atebimetinib + mGnP - - Raised $225 million of financing, including $25 million private placement with Sanofi - - Cash runway extended into 2029, including through topline readout of planned Phase 3 trial of atebimetinib + mGnP in first-line pancreatic cancer - - Granted U.S. composition of matter patent for atebimetinib that is expected to provide exclusivity into 2042 - - New...
Moleculin Announces Grant Funded Research Evaluating Annamycin for the...
Moleculin Announces Grant Funded Research Evaluating Annamycin for the Treatment of Pancreatic Cancer at UNC-Chapel Hill Preclinical research to be conducted at the University of North Carolina at Chapel Hill (UNC) Annamycin will be used in conjunction with novel agents and modalities Preclinical studies indicate Annamycin targets key factors in pancreatic cancer HOUSTON, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), a late-stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat cancers...
Iridex Reports Third Quarter 2025 Financial Results
Iridex Reports Third Quarter 2025 Financial Results MOUNTAIN VIEW, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results for the third quarter ended September 27, 2025. Third Quarter 2025 Financial Highlights Generated total revenue of $12.5 million, representing growth of 8% year-over-year compared to $11.6 million in the prior year quarterCyclo G6® product fa...
Ernexa Therapeutics to Present at Oxford Global’s Cell 2025
Ernexa Therapeutics to Present at Oxford Global’s Cell 2025 Sanjeev Luther, President and CEO to give an oral presentation and participate in a moderated panel discussion CAMBRIDGE, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced it will present at , Oxford Global’s premier event, being held on November 11 and 12, 2025 in London, UK. Details of the presentations are as follows: Title: Preparing Cell Therapies for ClinicsPresenter: Sanjeev Luther,...
- Jonathan Moreland
SLGN SILGAN HOLDINGS INC.
RHP RYMAN HOSPITALITY PROPERTIES INC.
PENN PENN NATIONAL GAMING INC.
NCLH NORWEGIAN CRUISE LINE HOLDINGS LTD.
MTDR MATADOR RESOURCES COMPANY
FDS FACTSET RESEARCH SYSTEMS INC.
LSCC LATTICE SEMICONDUCTOR CORPORATION
TIPT TIPTREE INC
ITGR INTEGER HOLDINGS CORPORATION
ICHR ICHOR HOLDINGS LTD.
KREF KKR REAL ESTATE FINANCE TRUST
HLNE HAMILTON LANE INCORPORATED CLASS A
SMPL SIMPLY GOOD FOODS CO
NWPP NEW PEOPLES BANKSHARES INC.
ALTM ALTUS MIDSTREAM COMPANY (A)
THRY THRYV HOLDINGS
AVO MISSION PRODUCE
UTZ UTZ BRANDS INC (A)
TBBK THE BANCORP
GECC INC.
RXO_w GREAT ELM CAPITAL CORP
PRAA RXO INC
GAM PORTFOLIO RECOVERY ASSOCIATES
BNTC INC.
FDBC GENERAL DE ALQUILER DE MAQUINARIA
ECF BENITEC BIOPHARMA INC
CAI FIDELITY D & D BANCORP INC
SINT ELLSWORTH FUND LTD
RMI CARIS LIFE SCIENCES INC
SENS SINTX TECHNOLOGIES INC.
RIVERNORTH OPPOR MUN INC FD INC
SENSEONICS HOLDINGS INC.
- Jonathan Moreland
SLGN SILGAN HOLDINGS INC.
RHP RYMAN HOSPITALITY PROPERTIES INC.
PENN PENN NATIONAL GAMING INC.
NCLH NORWEGIAN CRUISE LINE HOLDINGS LTD.
MTDR MATADOR RESOURCES COMPANY
FDS FACTSET RESEARCH SYSTEMS INC.
LSCC LATTICE SEMICONDUCTOR CORPORATION
TIPT TIPTREE INC
ITGR INTEGER HOLDINGS CORPORATION
ICHR ICHOR HOLDINGS LTD.
KREF KKR REAL ESTATE FINANCE TRUST
HLNE HAMILTON LANE INCORPORATED CLASS A
SMPL SIMPLY GOOD FOODS CO
NWPP NEW PEOPLES BANKSHARES INC.
ALTM ALTUS MIDSTREAM COMPANY (A)
THRY THRYV HOLDINGS
AVO MISSION PRODUCE
UTZ UTZ BRANDS INC (A)
TBBK THE BANCORP
GECC INC.
RXO_w GREAT ELM CAPITAL CORP
PRAA RXO INC
GAM PORTFOLIO RECOVERY ASSOCIATES
BNTC INC.
FDBC GENERAL DE ALQUILER DE MAQUINARIA
ECF BENITEC BIOPHARMA INC
CAI FIDELITY D & D BANCORP INC
SINT ELLSWORTH FUND LTD
RMI CARIS LIFE SCIENCES INC
SENS SINTX TECHNOLOGIES INC.
RIVERNORTH OPPOR MUN INC FD INC
SENSEONICS HOLDINGS INC.
- Dave Nicoski
- Ross LaDuke
Vital Signs: Actionable charts
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
ATNI ATN INTERNATIONAL INC.
35G GENPACT LIMITED
EXPE EXPEDIA GROUP INC.
CRK COMSTOCK RESOURCES INC.
AXTI AXT INC.
ALB ALBEMARLE CORPORATION
ACRE ARES COMMERCIAL REAL ESTATE
AGO ASSURED GUARANTY LTD.
HRTG HERITAGE INSURANCE HOLDINGS INC.
DRH DIAMONDROCK HOSPITALITY COMPANY
ELY CALLAWAY GOLF COMPANY
FLGT FULGENT GENETICS
DK DELEK US HOLDINGS INC
TALO TALOS ENERGY INC.
LASR NLIGHT
GLOB GAZIT-GLOBE LTD.
ARVN ARVINAS HOLDING
PLMR PALOMAR HOLDINGS
BW BABCOCK & WILCOX ENTERPRISES
TXG 10X GENOMICS INC CLASS A
PGNY PROGYNY
AMPY AMPLIFY ENERGY
EOSE EOS ENERGY ENTERPRISES INC (A)
MSGE MADISON SQUARE GARDEN ENTERTAINMENT
DOCN DIGITALOCEAN HLDGS INC
DSGN DESIGN THERAPEUTICS INC
FIGS FIGS INC
YOU ONTO INNOVATION INC.
PPTA CLEAR SECURE INC
AMPX PERPETUA RESOURCES CORP
OS AMPRIUS TECHNOLOGIES INC
SNDK ONESTREAM INC
CSIOX SANDISK CORP
BALY CATALYST PERINI STRATEGIC INCOM ORD
HOII BALLY'S CORPORATION
REX HOOD GROWTH & INCOME ETF
Codexis Announces Signing of Lease for GMP Manufacturing Facility
Codexis Announces Signing of Lease for GMP Manufacturing Facility REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced that it has signed a lease for a 34,000 square foot GMP manufacturing facility in Hayward, California. The multi-purpose facility will allow Codexis to expand its internal capabilities into GMP manufacturing of siRNA and other oligonucleotides using its ECO Synthesis platform. The company expects to begin modific...
Ernexa Therapeutics Reports Strong Quarterly Performance, Highlighting...
Ernexa Therapeutics Reports Strong Quarterly Performance, Highlighting Operational Execution and Progress Toward First-in-Human Cell Therapy Trials The Company’s operating loss declined by 44% year-over-year, reflecting its continued laser focus on relentless execution and progress in operational excellence Continued progress with lead program, ERNA-101, toward first-in-human Phase 1 study in platinum-resistant ovarian cancer (PROC), anticipated in H2 2026 CAMBRIDGE, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ERNA), developing innovative cell therapies for the treatment of a...
Village Farms Delivers Another Quarter of Record Financial Performance...
Village Farms Delivers Another Quarter of Record Financial Performance in Q3/25 Consolidated Net Sales Increased 21% YoY to $66.7 Million; International Export Sales Increased 758%Consolidated Net Income from Continuing Ops of $10.8 Million or $0.09 Per Share, Up YoY and Sequentially Consolidated Adjusted EBITDA of $20.2 Million or 30.3% of Sales; Both Company RecordsOperating Cash Flow of $24.4 Million Brings YTD Total to $46.7 Million; Company Ends Quarter with Approximately $88 Million in CashCanadian Cannabis Delivers Record Net Sales, Record Gross Margin of 56%, Record Adj. EBITDA and ...
- Jonathan Moreland
LNG CHENIERE ENERGY INC.
WM WASTE MANAGEMENT INC.
VRSK VERISK ANALYTICS INC
SLGN SILGAN HOLDINGS INC.
SFNC SIMMONS FIRST NATIONAL CORPORATION CLASS A
OHI OMEGA HEALTHCARE INVESTORS INC.
NCLH NORWEGIAN CRUISE LINE HOLDINGS LTD.
NBTB NBT BANCORP INC.
MTDR MATADOR RESOURCES COMPANY
MNRO MONRO INC
JBLU JETBLUE AIRWAYS CORPORATION
GBCI GLACIER BANCORP INC.
FISV FISERV INC.
FFIN FIRST FINANCIAL BANKSHARES INC
DENN DENNY'S CORPORATION
CNS COHEN & STEERS INC.
AMT AMERICAN TOWER CORPORATION
ASA ASA
NEWT NEWTEK BUSINESS SERVICES INC.
NCBS NICOLET BANKSHARES INC
RLMD RELMADA THERAPEUTICS
URE UR-ENERGY
KMI KINDER MORGAN INC CLASS P
MSM MSC INDUSTRIAL DIRECT CO. INC. CLASS A
NSC NORFOLK SOUTHERN CORPORATION
AJG ARTHUR J. GALLAGHER & CO.
WINA WINMARK CORP.
FND FLOOR & DECOR HOLDINGS INC. CLASS A
BX THE BLACKSTONE GROUP L.P.
MBIN MERCHANTS BANCORP
OBNK ORIGIN BANCORP
OSPN ONESPAN
FUSB FIRST US BANCSHARES INC
AVO MISSION PRODUCE
UTZ UTZ BRANDS INC (A)
OPCH OPTION CARE HEALTH INC
INTA INTAPP INC
CLVT CLARIVATE PLC
NVCT NUVECTIS PHARMA INC
BPRN BANK OF PRINCETON
GTE GRAN TIERRA ENERGY INC.
NCDL NUVEEN CHURCHILL DIRECT LENDING CORP
GAM GENERAL DE ALQUILER DE MAQUINARIA
LAW CS DISCO INC
GF THE NEW GERMANY FUND
ASST INC.
ASSET ENTITIES INC.
Ultralife Corporation Files Form 12b-25 Notification of Late Filing
Ultralife Corporation Files Form 12b-25 Notification of Late Filing NEWARK, N.Y., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) today announced that it has filed a Form 12b-25, Notification of Late Filing, with the Securities and Exchange Commission in connection with its Form 10-Q for the third quarter ended September 30, 2025. As previously disclosed, on October 31, 2024, Ultralife completed its acquisition of all outstanding shares of Electrochem Solutions, Inc. (“Electrochem”) from Integer Holdings Corporation (“Integer”). During the third quarter of 2025, th...
Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobar...
Xilio Therapeutics Announces Late-Breaking Phase 2 Data for Vilastobart in Patients with MSS mCRC and High Plasma Tumor Mutational Burden at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting 40% ORR in heavily pre-treated patients with MSS mCRC without liver metastases and with high plasma tumor mutational burden (TMB) Estimate 55% of patients with MSS CRC have high plasma TMB, representing a meaningful population with high unmet need Company to host conference call and webcast on Monday, November 10, 2025, at 4:30 p.m. ET with leading cancer experts to review the data WALTH...
Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immun...
Xilio Therapeutics Highlights Portfolio of Differentiated Masked Immunotherapies at Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting Preclinical data support best-in-class potential of masked T cell engager programs and platform utilizing Xilio’s ATACR and SEECR formats, including efficient masking, potent anti-tumor activity and broad therapeutic index Phase 1 data for efarindodekin alfa, a tumor-activated IL-12, demonstrated promising monotherapy anti-tumor activity in patients with advanced solid tumors and generally well-tolerated safety profile Phase 2 data for vilasto...
- Jonathan Moreland
NCLH NORWEGIAN CRUISE LINE HOLDINGS LTD.
MTDR MATADOR RESOURCES COMPANY
JBLU JETBLUE AIRWAYS CORPORATION
GBCI GLACIER BANCORP INC.
ASA ASA
TZOO TRAVELZOO
RLMD RELMADA THERAPEUTICS
NSC NORFOLK SOUTHERN CORPORATION
GCBC GREENE COUNTY BANCORP INC.
CSBR CHAMPIONS ONCOLOGY
RMCF ROCKY MOUNTAIN CHOCOLATE FACTORY INC.
CSBB C S B BANCORP OHIO
AVO MISSION PRODUCE
TDUP THREDUP INC.
NVCT NUVECTIS PHARMA INC
BPRN BANK OF PRINCETON
GTE GRAN TIERRA ENERGY INC.
Mercer International Inc. Reports Third Quarter 2025 Results
Mercer International Inc. Reports Third Quarter 2025 Results Selected Highlights Third quarter Operating EBITDA* of negative $28.1 million (net loss of $80.8 million), including a non-cash inventory impairment of $20.4 million, compared to positive $50.5 million (net loss of $17.6 million) in the same quarter of 2024Combined industry wide challenges stemming from the global economic and trade environment, higher fiber costs and pulp grade substitution intensified in the third quarter of 2025Continued execution of our "One Goal One Hundred" program, targeting $100 million in cost savings an...
Codexis Reports Third Quarter 2025 Financial Results
Codexis Reports Third Quarter 2025 Financial Results Announces signing of $37.8m Supply Assurance Agreement with Merck Organizational changes streamline company and reduce operational expenses Cash runway extended through 2027 REDWOOD CITY, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced financial results for the third quarter ended September 30, 2025. The company also provided a business update that includes signing a $37.8m Supply Ass...
Ernexa Therapeutics Showcases Strategic Partnership with Cellipont Bio...
Ernexa Therapeutics Showcases Strategic Partnership with Cellipont Bioservices to Advance Toward First-in-Human Trials on Virtual Investor “What This Means” Platform Access the “What This Means” segment CAMBRIDGE, Mass., Nov. 06, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced that it recently participated in a . As part of the segment, Sanjeev Luther, President and CEO of Ernexa, discussed the Company’s with Cellipont Bioservices focused on Engineering, Differe...
Full House Resorts Announces Strong Third Quarter Results
Full House Resorts Announces Strong Third Quarter Results - American Place Casino Continued Its Strong Growth, With Revenues Increasing 14.0% to a New Property Record in the Third Quarter of 2025 - Consolidated Operating Income Rose 40.3% to $3.4 Million in the Third Quarter of 2025; Net Loss Improved to $(7.7) Million from $(8.5) Million - Adjusted EBITDA Increased 26.1% to $14.8 Million in the Third Quarter of 2025, Reflecting Strong Results at American Place and a $2.1 Million Contribution from Chamonix/Bronco Billy’s LAS VEGAS, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Full House Resorts,...
Village Farms International Welcomes Brian Ellis as Chief Information ...
Village Farms International Welcomes Brian Ellis as Chief Information and Technology Officer Proven technology executive will oversee enterprise architecture and strategy as Company expands globally VANCOUVER, British Columbia, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today announced the hiring of Brian Ellis as the Company’s Chief Information and Technology Officer (CITO). In this newly created leadership position for the Company, Mr. Ellis will oversee Village Farms’ enterprise architecture and IT strategy as ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.